US Stock MarketDetailed Quotes

Aligos Therapeutics (ALGS)

Watchlist
  • 5.330
  • -0.020-0.37%
Trading Jun 18 11:41 ET
32.98MMarket Cap-2.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aligos Therapeutics (ALGS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.61%-23.13M
-2.18%-82.5M
-18.16%-21.75M
-21.11%-24.35M
20.46%-15.5M
8.08%-20.91M
-2.21%-80.74M
18.78%-18.4M
1.16%-20.1M
-43.16%-19.49M
Net income from continuing operations
-153.47%-23.04M
81.56%-24.19M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
Operating gains losses
94.48%-3.4M
-230.46%-60.18M
-101.95%-1.21M
3,904.76%4.21M
94.48%-1.68M
-527.84%-61.49M
2,010.34%46.13M
2,764.59%62.13M
--105K
---30.48M
Depreciation and amortization
67.65%855K
6.98%2.81M
11.62%749K
4.65%698K
39.02%848K
-24.33%510K
-14.57%2.62M
-13.42%671K
-2.06%667K
-20.68%610K
Change In working capital
140.60%1.56M
23.57%-3.79M
-518.97%-2.41M
148.15%1.53M
-77.38%930K
30.20%-3.84M
47.98%-4.96M
-33.11%-390K
48.69%-3.18M
539.35%4.11M
-Change in payables and accrued expense
169.85%2.12M
53.52%-620K
-166.55%-748K
208.58%2.15M
-74.72%1.01M
32.18%-3.04M
-2.54%-1.33M
-72.93%1.12M
-12.93%-1.98M
572.70%4M
-Change in other current assets
316.33%318K
-55.56%96K
-130.07%-681K
245.29%587K
144.20%337K
-172.06%-147K
-90.60%216K
74.81%-296K
121.82%170K
-93.63%138K
-Change in other current liabilities
-75.50%-881K
-16.12%-3.11M
-14.43%-817K
-13.88%-796K
-58.00%-997K
21.07%-502K
-12.32%-2.68M
-13.88%-714K
-21.57%-699K
-5.17%-631K
-Change in other working capital
----
86.95%-151K
66.67%-168K
38.75%-411K
-4.30%579K
74.28%-151K
85.78%-1.16M
80.93%-504K
78.31%-671K
896.05%605K
Cash from discontinued investing activities
Operating cash flow
-10.61%-23.13M
-2.18%-82.5M
-18.16%-21.75M
-21.11%-24.35M
20.46%-15.5M
8.08%-20.91M
-2.21%-80.74M
18.78%-18.4M
1.16%-20.1M
-43.16%-19.49M
Investing cash flow
Cash flow from continuing investing activities
179.27%34.93M
-106.94%-37.83M
-110.12%-2.02M
358.58%47.68M
-198.57%-39.42M
50.29%-44.07M
-140.64%-18.28M
285,414.29%19.97M
115,633.33%10.4M
59.95%39.99M
Net PPE purchase and sale
-60.47%-69K
-236.15%-437K
-228.57%-92K
-642.31%-193K
-1,457.14%-109K
37.68%-43K
-584.21%-130K
-300.00%-28K
-36.84%-26K
-150.00%-7K
Net investment purchase and sale
179.50%35M
-106.01%-37.39M
-109.65%-1.93M
359.29%47.88M
-198.28%-39.31M
50.30%-44.02M
-140.33%-18.15M
--20M
104,140.00%10.42M
60.06%40M
Cash from discontinued investing activities
Investing cash flow
179.27%34.93M
-106.94%-37.83M
-110.12%-2.02M
358.58%47.68M
-198.57%-39.42M
50.29%-44.07M
-140.64%-18.28M
285,414.29%19.97M
115,633.33%10.4M
59.95%39.99M
Financing cash flow
Cash flow from continuing financing activities
-100.06%-62K
28,529.58%101.64M
26.80%123K
-1,225.00%-53K
-162.99%-177K
535,584.21%101.74M
-99.60%355K
-99.89%97K
80.95%-4K
-32.13%281K
Net issuance payments of debt
---62K
83.13%-14K
93.02%-3K
-100.00%-10K
93.75%-1K
--0
13.54%-83K
-975.00%-43K
76.19%-5K
65.96%-16K
Net common stock issuance
--0
--101.35M
----
----
---356K
--101.74M
--0
----
----
--0
Proceeds from stock option exercised by employees
----
-30.59%304K
-72,399.29%-101.22M
10,134,200.00%101.34M
----
----
-99.38%438K
-99.80%140K
--1K
-35.57%297K
Cash from discontinued financing activities
Financing cash flow
-100.06%-62K
28,529.58%101.64M
26.80%123K
-1,225.00%-53K
-162.99%-177K
535,584.21%101.74M
-99.60%355K
-99.89%97K
80.95%-4K
-32.13%281K
Net cash flow
Beginning cash position
-50.38%18.41M
-72.67%37.11M
18.66%42.06M
-58.42%18.77M
203.17%73.87M
-72.67%37.11M
66.67%135.77M
-49.73%35.44M
-50.32%45.15M
-69.18%24.37M
Current changes in cash
-68.07%11.74M
81.05%-18.69M
-1,519.15%-23.64M
339.88%23.29M
-365.16%-55.1M
133.00%36.77M
-281.67%-98.67M
-97.45%1.67M
52.34%-9.71M
76.08%20.78M
End cash Position
-59.18%30.15M
-50.38%18.41M
-50.38%18.41M
18.66%42.06M
-58.42%18.77M
203.17%73.87M
-72.67%37.11M
-72.67%37.11M
-49.73%35.44M
-50.32%45.15M
Free cash flow
-10.71%-23.2M
-2.56%-82.94M
-18.48%-21.84M
-21.92%-24.54M
19.93%-15.61M
8.17%-20.95M
-2.35%-80.87M
18.68%-18.43M
1.09%-20.13M
-43.29%-19.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.61%-23.13M-2.18%-82.5M-18.16%-21.75M-21.11%-24.35M20.46%-15.5M8.08%-20.91M-2.21%-80.74M18.78%-18.4M1.16%-20.1M-43.16%-19.49M
Net income from continuing operations -153.47%-23.04M81.56%-24.19M75.80%-19.88M-63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M
Operating gains losses 94.48%-3.4M-230.46%-60.18M-101.95%-1.21M3,904.76%4.21M94.48%-1.68M-527.84%-61.49M2,010.34%46.13M2,764.59%62.13M--105K---30.48M
Depreciation and amortization 67.65%855K6.98%2.81M11.62%749K4.65%698K39.02%848K-24.33%510K-14.57%2.62M-13.42%671K-2.06%667K-20.68%610K
Change In working capital 140.60%1.56M23.57%-3.79M-518.97%-2.41M148.15%1.53M-77.38%930K30.20%-3.84M47.98%-4.96M-33.11%-390K48.69%-3.18M539.35%4.11M
-Change in payables and accrued expense 169.85%2.12M53.52%-620K-166.55%-748K208.58%2.15M-74.72%1.01M32.18%-3.04M-2.54%-1.33M-72.93%1.12M-12.93%-1.98M572.70%4M
-Change in other current assets 316.33%318K-55.56%96K-130.07%-681K245.29%587K144.20%337K-172.06%-147K-90.60%216K74.81%-296K121.82%170K-93.63%138K
-Change in other current liabilities -75.50%-881K-16.12%-3.11M-14.43%-817K-13.88%-796K-58.00%-997K21.07%-502K-12.32%-2.68M-13.88%-714K-21.57%-699K-5.17%-631K
-Change in other working capital ----86.95%-151K66.67%-168K38.75%-411K-4.30%579K74.28%-151K85.78%-1.16M80.93%-504K78.31%-671K896.05%605K
Cash from discontinued investing activities
Operating cash flow -10.61%-23.13M-2.18%-82.5M-18.16%-21.75M-21.11%-24.35M20.46%-15.5M8.08%-20.91M-2.21%-80.74M18.78%-18.4M1.16%-20.1M-43.16%-19.49M
Investing cash flow
Cash flow from continuing investing activities 179.27%34.93M-106.94%-37.83M-110.12%-2.02M358.58%47.68M-198.57%-39.42M50.29%-44.07M-140.64%-18.28M285,414.29%19.97M115,633.33%10.4M59.95%39.99M
Net PPE purchase and sale -60.47%-69K-236.15%-437K-228.57%-92K-642.31%-193K-1,457.14%-109K37.68%-43K-584.21%-130K-300.00%-28K-36.84%-26K-150.00%-7K
Net investment purchase and sale 179.50%35M-106.01%-37.39M-109.65%-1.93M359.29%47.88M-198.28%-39.31M50.30%-44.02M-140.33%-18.15M--20M104,140.00%10.42M60.06%40M
Cash from discontinued investing activities
Investing cash flow 179.27%34.93M-106.94%-37.83M-110.12%-2.02M358.58%47.68M-198.57%-39.42M50.29%-44.07M-140.64%-18.28M285,414.29%19.97M115,633.33%10.4M59.95%39.99M
Financing cash flow
Cash flow from continuing financing activities -100.06%-62K28,529.58%101.64M26.80%123K-1,225.00%-53K-162.99%-177K535,584.21%101.74M-99.60%355K-99.89%97K80.95%-4K-32.13%281K
Net issuance payments of debt ---62K83.13%-14K93.02%-3K-100.00%-10K93.75%-1K--013.54%-83K-975.00%-43K76.19%-5K65.96%-16K
Net common stock issuance --0--101.35M-----------356K--101.74M--0----------0
Proceeds from stock option exercised by employees -----30.59%304K-72,399.29%-101.22M10,134,200.00%101.34M---------99.38%438K-99.80%140K--1K-35.57%297K
Cash from discontinued financing activities
Financing cash flow -100.06%-62K28,529.58%101.64M26.80%123K-1,225.00%-53K-162.99%-177K535,584.21%101.74M-99.60%355K-99.89%97K80.95%-4K-32.13%281K
Net cash flow
Beginning cash position -50.38%18.41M-72.67%37.11M18.66%42.06M-58.42%18.77M203.17%73.87M-72.67%37.11M66.67%135.77M-49.73%35.44M-50.32%45.15M-69.18%24.37M
Current changes in cash -68.07%11.74M81.05%-18.69M-1,519.15%-23.64M339.88%23.29M-365.16%-55.1M133.00%36.77M-281.67%-98.67M-97.45%1.67M52.34%-9.71M76.08%20.78M
End cash Position -59.18%30.15M-50.38%18.41M-50.38%18.41M18.66%42.06M-58.42%18.77M203.17%73.87M-72.67%37.11M-72.67%37.11M-49.73%35.44M-50.32%45.15M
Free cash flow -10.71%-23.2M-2.56%-82.94M-18.48%-21.84M-21.92%-24.54M19.93%-15.61M8.17%-20.95M-2.35%-80.87M18.68%-18.43M1.09%-20.13M-43.29%-19.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.78%
Sample Name
Sample Code
 +23.56%
Sample Name
Sample Code
 -12.64%
4
United States Gasoline Fund Lp
UGA
-13.22%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-13.62%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +8.97%
Sample Name
Sample Code
 +8.91%
4
Zai Lab
ZLAB
+4.88%
5
Amer Sports
AS
+2.58%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -